日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Diagnostic accuracy of (18)F-FDG PET/CT in muscle-invasive bladder cancer: rationale and design of the MIBC-PET study

(18)F-FDG PET/CT 在肌层浸润性膀胱癌诊断中的准确性:MIBC-PET 研究的原理和设计

Urso, Luca; Feletti, Francesco; Lancia, Federica; Canella, Francesca; Cittanti, Corrado; Badrane, Ilham; Adamantiadis, Sara; Uccelli, Licia; Iudicello, Antonella; Nieri, Alberto; Caracciolo, Matteo; Rambaldi, Ilaria; Bisi, Riccardo; Manco, Luigi; Bagni, Ilaria; Guidoboni, Massimo; Calabrò, Luana; Ippolito, Carmelo; Giganti, Melchiore; Bartolomei, Mirco

Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma

晚期黑色素瘤患者接受纳武利尤单抗联合伊匹木单抗治疗的最终10年疗效

Wolchok, Jedd D; Chiarion-Sileni, Vanna; Rutkowski, Piotr; Cowey, C Lance; Schadendorf, Dirk; Wagstaff, John; Queirolo, Paola; Dummer, Reinhard; Butler, Marcus O; Hill, Andrew G; Postow, Michael A; Gaudy-Marqueste, Caroline; Medina, Theresa; Lao, Christopher D; Walker, John; Márquez-Rodas, Iván; Haanen, John B A G; Guidoboni, Massimo; Maio, Michele; Schöffski, Patrick; Carlino, Matteo S; Sandhu, Shahneen; Lebbé, Céleste; Ascierto, Paolo A; Long, Georgina V; Ritchings, Corey; Nassar, Ayman; Askelson, Margarita; Benito, Melanie Pe; Wang, Wenjia; Hodi, F Stephen; Larkin, James

Adjuvant dendritic cell-based immunotherapy in melanoma: insights into immune cell dynamics and clinical evidence from a phase II trial

基于树突状细胞的辅助免疫疗法在黑色素瘤治疗中的应用:免疫细胞动力学的见解和来自 II 期试验的临床证据

Bulgarelli, Jenny; Piccinini, Claudia; Scarpi, Emanuela; Gentili, Giorgia; Renzi, Laura; Carloni, Silvia; Limarzi, Francesco; Pancisi, Elena; Granato, Anna Maria; Petrini, Massimiliano; De Rosa, Francesco; Guidoboni, Massimo; Fanelli, Dalila; Tumedei, Maria Maddalena; Tazzari, Marcella; Baravelli, Stefano; Bronico, Ilaria; Cortesi, Pietro; Pignatta, Sara; Capelli, Laura; Ancarani, Valentina; Foschi, Giovanni; Turci, Livia; Tauceri, Francesca; Framarini, Massimo; Ridolfi, Laura

Circulating memory B-cell receptor repertoire analysis identifies novel candidate antibodies against metastatic melanoma in immunotherapy-responsive patients

循环记忆B细胞受体库分析可识别出免疫治疗有效患者体内针对转移性黑色素瘤的新型候选抗体

Nicolini, Fabio; Gaimari, Anna; Mazzotti, Lucia; De Lucia, Anna; Ghirelli, Miriana; Ancarani, Valentina; Borges de Souza, Patricia; Zurlo, Matteo; Gazzola, Luca; Magnoni, Chiara; Capobianco, Simona; Angeli, Davide; Bravaccini, Sara; Cerchione, Claudio; Guidoboni, Massimo; Lanfrancone, Luisa; Marocchi, Federica; Maltoni, Roberta; Tumedei, Maria Maddalena; Limarzi, Francesco; Pasini, Luigi; Ridolfi, Laura; Mazza, Massimiliano

A Hybrid ODE-NN Framework for Modeling Incomplete Physiological Systems

一种用于建模不完全生理系统的混合ODE-NN框架

Demirkaya, Ahmet; Lockwood, Kyle; Stratis, Georgios; Imbiriba, Tales; Ilies, Iulian; Rampersad, Sumientra; Alhajjar, Elie; Guidoboni, Giovanna; Danziger, Zachary C; Erdogmus, Deniz

Nectin-4-Targeting Radiotracers: Novel Theranostic Agents for Precision Oncology in Cancer

靶向Nectin-4的放射性示踪剂:用于癌症精准治疗的新型诊疗一体化药物

Speltri, Giorgia; Badrane, Ilham; Napolitano, Rebecca; Boschi, Alessandra; Uccelli, Licia; Filippi, Luca; Guidoboni, Massimo; Brunelli, Matteo; Lancia, Federica; Martini, Petra; Iudicello, Antonella; Cittanti, Corrado; Bartolomei, Mirco; Urso, Luca

Comparing Interface Conditions for a 3D-0D Multiscale Interface Coupling With Applications in Tissue Perfusion

比较三维-零维多尺度界面耦合的界面条件及其在组织灌注中的应用

Bociu, L; Broussard, M; Guidoboni, G; Prada, D; Strikwerda, S

Retinal Venous Vulnerability in Primary Open Angle Glaucoma: The Combined Effects of Intraocular Pressure and Blood Pressure with Application to the Thessaloniki Eye Study

原发性开角型青光眼视网膜静脉脆弱性:眼压和血压的联合作用及其在塞萨洛尼基眼科研究中的应用

Rai, Rajat; Guidoboni, Giovanna; Wikle, Christopher K; Topouzis, Fotis; Siesky, Brent; Vercellin, Alice Verticchio; Antman, Gal; Harris, Alon

ANALYSIS OF A MULTISCALE INTERFACE PROBLEM BASED ON THE COUPLING OF PARTIAL AND ORDINARY DIFFERENTIAL EQUATIONS TO MODEL TISSUE PERFUSION

基于偏微分方程和常微分方程耦合的多尺度界面问题分析及其在组织灌注模型中的应用

Bociu, Lorena; Broussard, Matthew; Guidoboni, Giovanna; Strikwerda, Sarah

Sequential immunotherapy and targeted therapy for metastatic BRAF V600 mutated melanoma: 4-year survival and biomarkers evaluation from the phase II SECOMBIT trial

转移性 BRAF V600 突变黑色素瘤的序贯免疫治疗和靶向治疗:II 期 SECOMBIT 试验的 4 年生存率和生物标志物评估

Paolo A Ascierto, Milena Casula, Jenny Bulgarelli, Marina Pisano, Claudia Piccinini, Luisa Piccin, Antonio Cossu, Mario Mandalà, Pier Francesco Ferrucci, Massimo Guidoboni, Piotr Rutkowski, Virginia Ferraresi, Ana Arance, Michele Guida, Evaristo Maiello, Helen Gogas, Erika Richtig, Maria Teresa Fier